Lack of association found between vitamin D and miscarriage risk
March 8th 2024Investigating the relationship between 25-hydroxyvitamin D (25OHD) levels and miscarriage risk, a recent study utilizing mendelian randomization analysis found minimal causal association, suggesting no significant impact of vitamin D deficiency on miscarriage risk.
Read More
Study finds no link between prenatal antiseizure medication exposure and child epilepsy risk
March 8th 2024Recent research suggested that despite concerns about valproate use during pregnancy, prenatal exposure to antiseizure medications does not appear to raise the risk of epilepsy in offspring.
Read More
Fish and omega-3 supplement intake found lacking in pregnant women
March 8th 2024A recent study highlighted the disparity between dietary recommendations and actual intake of fish and omega-3 supplements among pregnant women, underscoring the need for targeted public health interventions to address this shortfall.
Read More
NIH study finds long-acting ART safe for HIV suppression in adolescents
March 7th 2024Research presented at the 2024 Conference on Retroviruses and Opportunistic Infections reveals that long-acting injectable antiretroviral therapy provides improved HIV suppression with minimal adverse effects, offering a promising alternative for adolescents and individuals struggling with daily oral regimens.
Read More
HIV remission among children reported over 1 year after treatment interruption
March 7th 2024Research presented at the 2024 Conference on Retroviruses and Opportunistic Infections reveals that 4 children, treated with antiretroviral therapy within 48 hours of birth, have achieved over a year of HIV remission.
Read More
Evaluating GeneXpert point-of-care testing for STIs
March 6th 2024A recent study assessed the effectiveness of GeneXpert point-of-care testing in detecting chlamydia, gonorrhoea, and trichomonas, revealing promising results but highlighting concerns over sensitivity rates, particularly for trichomonas.
Read More
Dapivirine ring and oral PrEP found safe for preventing HIV in pregnant women
March 6th 2024Recent findings affirm the safety of monthly dapivirine vaginal rings and daily oral PrEP with tenofovir disoproxil fumarate and emtricitabine in preventing HIV transmission among pregnant cisgender women.
Read More
Study finds AI tool MySTIRisk effectively identifies high-risk STI subgroups
March 5th 2024A recent study revealed the effectiveness of the AI tool MySTIRisk in pinpointing high-risk subgroups for HIV and other sexually transmitted infections, shedding light on improved risk assessment and testing accessibility.
Read More
Dexamethasone dosage in preterm births: Efficacy found from 5-mg dose
March 5th 2024A recent study compared the efficacy and safety of 5-mg versus 6-mg doses of dexamethasone in preventing neonatal respiratory distress syndrome in preterm births, shedding light on dosage optimization for improved neonatal outcomes.
Read More
Risk of graft loss in pregnant kidney transplant recipients
March 5th 2024A study examines the association between donor types and obstetrical and graft morbidity risks among pregnant kidney transplant recipients, revealing increased short- and long-term graft loss risk from pregnancy after deceased donor kidney transplant compared to living donor kidney transplant.
Read More
Study: Amniocentesis doesn't increase hepatitis B transmission risk in infants
March 4th 2024A recent study finds that, contrary to previous concerns, amniocentesis does not heighten the risk of mother-to-child transmission of hepatitis B virus among infants following a standardized immunoprophylaxis schedule.
Read More
Assessing the impact of oxytocin use on postpartum hemorrhage
March 1st 2024A recent study reveals that while oxytocin dosage correlates with a slight uptick in postpartum hemorrhage (PPH) risk, the use of oxytocin augmentation doesn't significantly increase PPH or blood loss when compared to patients with similar obstetric profiles.
Read More
Study: Antibiotic therapy reduces intraamniotic inflammation in second trimester idiopathic bleeding
March 1st 2024A recent study revealed the efficacy of antibiotic therapy in reducing intraamniotic inflammation among patients experiencing idiopathic bleeding in the second trimester of pregnancy, shedding light on potential management strategies for this condition.
Read More
Placental oxygenation's link to fetal brain volumes
February 29th 2024Discover how transverse relaxation time mapping, a sensitive magnetic resonance imaging-based technique, unveils the relationship between placental oxygenation and fetal brain development, shedding light on potential biomarkers for assessing fetal well-being.
Read More
Enhancing ePN platforms for gonorrhea and chlamydia
February 28th 2024Recent study reveals the need for customizable electronic partner notification platforms for gonorrhea and chlamydia, highlighting the need for tailored solutions to improve sexually transmitted infection partner services.
Read More
Unveiling metabolic markers of Candida albicans infection
February 27th 2024Discover how metabolomics sheds light on potential biomarkers for early detection and treatment of Candida albicans-induced vulvovaginal candidiasis, offering crucial insights into the pathogenesis of this prevalent inflammatory condition.
Read More
Comparing IV and IM oxytocin for postpartum hemorrhage
February 27th 2024A recent investigation finds comparable safety and effectiveness between intravenous and intramuscular oxytocin administration, suggesting intramuscular administration may be preferable for postpartum hemorrhage prevention.
Read More
Understanding patient perspectives on fetal malpresentation management
February 26th 2024A recent investigation sheds light on patient preferences and concerns regarding external cephalic version versus cesarean section for managing fetal malpresentation, revealing gaps in counseling and the desire for more information.
Read More
Demystifying bacterial vaginosis: Understanding, treatment, and breaking stigmas
February 26th 2024Misunderstandings surrounding bacterial vaginosis can delay treatment, but advancements such as XACIATO offer effective solutions, emphasizing the importance of open communication and continued research for comprehensive women's health care.
Read More
FDA approves enmetazobactam for treatment of cUTIs
February 23rd 2024Enmetazobactam (Exblifep; Orchid Pharma) gains FDA approval for treating complicated urinary tract infections in adults after demonstrating superiority over piperacillin-tazobactam in clinical cure and microbiological eradication in a global phase 3 trial.
Read More